Abvc Biopharma, Inc. ABVC
What this company does
Written from the business description in ABVC BioPharma, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 3 March 2026. Every sentence was checked against that document before publication.
Revenue compounded at −9.3% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Each USD of equity lost 128 cents this year.
EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | · | · | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | · | · | · | · | · | · | · | · |
| Income tax $B | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 | −0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Free cash flow $B | · | · | −0.0 | −0.0 | −0.0 | · | · | · | · | · | · | · | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.39 | −0.42 | −1.80 | −5.19 | −0.51 | −0.50 | −0.21 | −0.48 | −0.02 | −0.06 | −0.01 | −0.01 | 0.00 | −0.04 | −0.31 | −0.47 |
| Dividend / sh $ | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
| ROE % | −128.2 | −352.7 | −334.8 | −275.0 | −209.1 | −644.5 | · | · | · | · | −9.7 | · | · | · | · | · |
| Shares out B | 0.03 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | 0.01 | 0.21 | 0.21 | 0.17 | 0.00 | 0.05 | 0.01 | 0.01 | 0.03 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Reconciled in 15 of 19 fiscal years. 1 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 23 checks could not be computed.